Richard Armitage
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Richard Armitage has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Laura B. Nellums
College of Population Health, Health Sciences Center, University of New Mexico, Albuquerque, NM 87131, USA
12 shared publications Eric Williamson
Richard C. Armitage is the general practitioner in the Academic Unit of Population and Lifespan Sciences, School of Medicine at the University of Nottingham, Clinical Sciences Building, Nottingham City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, England ([ protected]). Please address all correspondence to Richard C. Armitage
2 shared publicationsAleksandr Kamyshnyi
Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
1 shared publicationAlexander Ghionis
1 shared publicationAmani Al-Oraibi
University of Leicester Department of Respiratory Sciences
1 shared publicationAna Teresa Afonso
UK-Med, Manchester, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by Springer Nature in Journal of Academic Ethics
- Vol. 24 (4) , 102
Should Non-Directed Altruistic Living Organ Donors Who Research Non-Directed Altruistic Living Organ Donation Declare Their Donations in their Work?
Some non-directed altruistic living organ donors (NDALODs) also conduct research on organ donation practices. This raises questions about potential conflicts of interest (COI) and whether donors should disclose their donation status in their research publications. According to standard definitions, such donors hold a non-financial COI through personal experience with their research subject and implicit advocacy for donation practices. However, requiring disclosure creates two significant ethical concerns: first, requiring researchers to reveal personal health information violates their privacy; second, disclosure contravenes the fundamental anonymity principle of non-directed altruistic living organ donation, potentially allowing recipients to identify donors and compromising both parties’ safety. Reflexivity, borrowed from social sciences, could help researchers acknowledge their biases, but still requires published statements that raise privacy and confidentiality concerns. Instead, a flexible, context-sensitive approach is proposed. NDALOD researchers should not be required to disclose their donation status but may do so voluntarily under certain conditions. Further recommendations are suggested for the practices of academic journals. Ultimately, complete transparency cannot be achieved while preserving donor privacy and confidentiality meaning some potential bias must be accepted as a necessary trade-off for protecting these ethical principles.
- 13 November 2026
- Published by Springer Nature in Journal of Academic Ethics
- Vol. 24 (4) , 102
Open AccessShould Non-Directed Altruistic Living Organ Donors Who Research Non-Directed Altruistic Living Organ Donation Declare Their Donations in their Work?
Some non-directed altruistic living organ donors (NDALODs) also conduct research on organ donation practices. This raises questions about potential conflicts of interest (COI) and whether donors should disclose their donation status in their research publications. According to standard definitions, such donors hold a non-financial COI through personal experience with their research subject and implicit advocacy for donation practices. However, requiring disclosure creates two significant ethical concerns: first, requiring researchers to reveal personal health information violates their privacy; second, disclosure contravenes the fundamental anonymity principle of non-directed altruistic living organ donation, potentially allowing recipients to identify donors and compromising both parties’ safety. Reflexivity, borrowed from social sciences, could help researchers acknowledge their biases, but still requires published statements that raise privacy and confidentiality concerns. Instead, a flexible, context-sensitive approach is proposed. NDALOD researchers should not be required to disclose their donation status but may do so voluntarily under certain conditions. Further recommendations are suggested for the practices of academic journals. Ultimately, complete transparency cannot be achieved while preserving donor privacy and confidentiality meaning some potential bias must be accepted as a necessary trade-off for protecting these ethical principles.
- Open Access
- 11 November 2026
- Published by SAGE Publications in Journal of the Royal Society of Medicine
Clinical recognition of high-consequence infectious diseases and bioterrorism agents: an oversight in UK biological security
- 11 November 2026
- Published by SAGE Publications in Journal of the Royal Society of Medicine
Open AccessClinical recognition of high-consequence infectious diseases and bioterrorism agents: an oversight in UK biological security
- Open Access
- 27 October 2026
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 27, e136
Artificial intelligence policies in academic primary health care: a review of journals and their publishers
Background: The rapid adoption of AI tools in academic research has created uncertainty about appropriate use in manuscript preparation, particularly in primary health care where clear guidance is essential for maintaining research integrity across diverse settings. Objectives: This review aimed to assess the availability and content of AI policies across primary health care journals and their publishers. Methods: We identified primary health care journals through searches of SCImago Journal & Country Rank, Google Scholar, and a Google search. After screening for English language, functioning webpages, recent publications, and exclusion of predatory journals, 41 journals were included. Two reviewers independently reviewed journal homepages, author guidelines, submission policies, and editorial policies for AI-related statements at both journal and publisher levels between 18 and 21 July 2025. Results: Of 41 journals assessed, 33 (80.5%) had publicly available AI policies – 21 (51.2%) at journal level and 12 (29.3%) at publisher level. Eight journals (19.5%) had no identifiable public AI policy. All identified policies were permissive toward AI use but varied in requirements across five key areas: disclosure of AI use, acceptable AI tasks, AI authorship considerations, author responsibility, and peer review guidelines. Conclusion: While most primary health care journals have established AI policies, significant gaps remain in accessibility and standardization. The fragmented governance landscape, characterized by inconsistent policy locations and requirements, creates confusion for authors and might compromise research integrity. Standardized, easily accessible AI policies are needed to enable researchers to harness AI’s potential while maintaining transparency and scientific rigour essential to primary health care research.
- 27 October 2026
- Published by Cambridge University Press (CUP) in Primary Health Care Research & Development
- Vol. 27, e136
Open AccessArtificial intelligence policies in academic primary health care: a review of journals and their publishers
Background: The rapid adoption of AI tools in academic research has created uncertainty about appropriate use in manuscript preparation, particularly in primary health care where clear guidance is essential for maintaining research integrity across diverse settings. Objectives: This review aimed to assess the availability and content of AI policies across primary health care journals and their publishers. Methods: We identified primary health care journals through searches of SCImago Journal & Country Rank, Google Scholar, and a Google search. After screening for English language, functioning webpages, recent publications, and exclusion of predatory journals, 41 journals were included. Two reviewers independently reviewed journal homepages, author guidelines, submission policies, and editorial policies for AI-related statements at both journal and publisher levels between 18 and 21 July 2025. Results: Of 41 journals assessed, 33 (80.5%) had publicly available AI policies – 21 (51.2%) at journal level and 12 (29.3%) at publisher level. Eight journals (19.5%) had no identifiable public AI policy. All identified policies were permissive toward AI use but varied in requirements across five key areas: disclosure of AI use, acceptable AI tasks, AI authorship considerations, author responsibility, and peer review guidelines. Conclusion: While most primary health care journals have established AI policies, significant gaps remain in accessibility and standardization. The fragmented governance landscape, characterized by inconsistent policy locations and requirements, creates confusion for authors and might compromise research integrity. Standardized, easily accessible AI policies are needed to enable researchers to harness AI’s potential while maintaining transparency and scientific rigour essential to primary health care research.
- 26 October 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (7)
Physicians for AI Safety: We Must Prevent Harm From Advanced AI
- 26 October 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (7)
Physicians for AI Safety: We Must Prevent Harm From Advanced AI
- Open Access
- 25 August 2026
- Published by Springer Nature in Journal of Bioethical Inquiry
- p. 1-9
Should All Living Donors Receive Equal Priority in Organ Allocation? An Equality of Opportunity Perspective
Priority rules in organ allocation confer preferential access to organs for individuals who have previously donated or pledged to do so. Several countries extend such rules to living donors. Yet existing systems do not distinguish between different kinds of living donation. This paper examines whether all living donors should receive equal priority or whether distinctions are justified, using John Roemer’s conception of equality of opportunity as the analytical framework. The paper develops a typology of living donation along two axes: interest-based versus altruistic motivation and directed versus non-directed allocation. Interest-based directed donation occurs when someone gives directly to a loved one; interest-based non-directed donation when they donate through paired or pooled exchange. Altruistic directed donation involves giving to a specified stranger, often following a media appeal, while altruistic non-directed donation involves donating to an unspecified recipient, sometimes initiating a donor chain. Holding circumstances constant, equality of opportunity appears to favour greater recognition for altruistic non-directed donation, as it involves the least offset effort. However, closer attention to circumstances—such as awareness of donation pathways, illness within a personal network, and exposure to media campaigns—suggests that differences between donor types cannot be attributed to effort alone. Moreover, many altruistic non-directed donors report a sense of moral duty and psychological relief, indicating that their effort is also partially offset by personal benefit. The analysis concludes that priority rules might recognise all living donors but any additional recognition for particular donor types should be modest and sensitive to circumstance and motivation.
- 25 August 2026
- Published by Springer Nature in Journal of Bioethical Inquiry
- p. 1-9
Open AccessShould All Living Donors Receive Equal Priority in Organ Allocation? An Equality of Opportunity Perspective
Priority rules in organ allocation confer preferential access to organs for individuals who have previously donated or pledged to do so. Several countries extend such rules to living donors. Yet existing systems do not distinguish between different kinds of living donation. This paper examines whether all living donors should receive equal priority or whether distinctions are justified, using John Roemer’s conception of equality of opportunity as the analytical framework. The paper develops a typology of living donation along two axes: interest-based versus altruistic motivation and directed versus non-directed allocation. Interest-based directed donation occurs when someone gives directly to a loved one; interest-based non-directed donation when they donate through paired or pooled exchange. Altruistic directed donation involves giving to a specified stranger, often following a media appeal, while altruistic non-directed donation involves donating to an unspecified recipient, sometimes initiating a donor chain. Holding circumstances constant, equality of opportunity appears to favour greater recognition for altruistic non-directed donation, as it involves the least offset effort. However, closer attention to circumstances—such as awareness of donation pathways, illness within a personal network, and exposure to media campaigns—suggests that differences between donor types cannot be attributed to effort alone. Moreover, many altruistic non-directed donors report a sense of moral duty and psychological relief, indicating that their effort is also partially offset by personal benefit. The analysis concludes that priority rules might recognise all living donors but any additional recognition for particular donor types should be modest and sensitive to circumstance and motivation.
- Open Access
Recognition of Category A bioterrorism agent syndromes by final-year medical students in the UK: a pilot study
Background: Early recognition of presentations consistent with the deliberate release of a Category A bioterrorism agent is essential for rapid isolation, public health notification, and containment. The ability of UK clinicians-in-training to recognise these syndromes is unstudied. This pilot assessed final-year UK medical students’ ability to recognise these syndromes. Methods: A pilot cross-sectional online survey of final-year UK medical students used single-best-answer clinical vignettes depicting syndromes associated with Category A bioterrorism agents (BT vignettes) and clinically overlapping non-bioterrorism syndromes (NBT vignettes). Performance was summarised as the proportion of vignettes correctly identified, with primary analysis comparing within-participant BT and NBT performance. Results: Twenty-five participants completed the survey. Participants performed worse on BT vignettes (M = 0.55) than on NBT vignettes (M = 0.81), with a within-participant difference of −0.26 (95% CI [-0.35, −0.18]; t(24) = -6.33, p < 0.001; Cohen’s dz = -1.27). Botulism (96.0%) and Ebola virus disease (88.0%) were recognised by most participants, while anthrax (40.0%), pneumonic plague (28.0%), and smallpox (24.0%) were recognised by fewer than half. Conclusion: This pilot provides the first UK evidence of a substantial diagnostic deficit in final-year medical students’ recognition of Category A bioterrorism agent syndromes.
Open AccessRecognition of Category A bioterrorism agent syndromes by final-year medical students in the UK: a pilot study
Background: Early recognition of presentations consistent with the deliberate release of a Category A bioterrorism agent is essential for rapid isolation, public health notification, and containment. The ability of UK clinicians-in-training to recognise these syndromes is unstudied. This pilot assessed final-year UK medical students’ ability to recognise these syndromes. Methods: A pilot cross-sectional online survey of final-year UK medical students used single-best-answer clinical vignettes depicting syndromes associated with Category A bioterrorism agents (BT vignettes) and clinically overlapping non-bioterrorism syndromes (NBT vignettes). Performance was summarised as the proportion of vignettes correctly identified, with primary analysis comparing within-participant BT and NBT performance. Results: Twenty-five participants completed the survey. Participants performed worse on BT vignettes (M = 0.55) than on NBT vignettes (M = 0.81), with a within-participant difference of −0.26 (95% CI [-0.35, −0.18]; t(24) = -6.33, p < 0.001; Cohen’s dz = -1.27). Botulism (96.0%) and Ebola virus disease (88.0%) were recognised by most participants, while anthrax (40.0%), pneumonic plague (28.0%), and smallpox (24.0%) were recognised by fewer than half. Conclusion: This pilot provides the first UK evidence of a substantial diagnostic deficit in final-year medical students’ recognition of Category A bioterrorism agent syndromes.
- Open Access
- 12 August 2026
- Published by Taylor & Francis in Global Public Health
- Vol. 21 (1)
The case for near-term artificial intelligence risks to be considered a public health problem
Artificial intelligence (AI) now permeates most sectors, including health and healthcare, where its potential benefits are considerable. However, as capabilities expand and deployment accelerates, ...
- 12 August 2026
- Published by Taylor & Francis in Global Public Health
- Vol. 21 (1)
Open AccessThe case for near-term artificial intelligence risks to be considered a public health problem
Artificial intelligence (AI) now permeates most sectors, including health and healthcare, where its potential benefits are considerable. However, as capabilities expand and deployment accelerates, ...
- 9 June 2026
- Published by SAGE Publications in Health Security
- Vol. 24 (3) , 285-286
Recognizing Bioterrorism-Related Acute Illness in Clinical Practice: An Urgent Research Priority
- 9 June 2026
- Published by SAGE Publications in Health Security
- Vol. 24 (3) , 285-286
Recognizing Bioterrorism-Related Acute Illness in Clinical Practice: An Urgent Research Priority
- 8 June 2026
- Published by BMJ in Considerations in Medicine
- Vol. 4 (1) , e000060
Why public health needs to engage with existential risk studies: a call for collaboration
Background Existential and global catastrophic risks are low-probability, high-impact threats with profound implications for population health and health equity, yet they remain largely outside mainstream public health activities. This article introduces Existential Risk Studies (ERS) as an emerging interdisciplinary field that analyses existential and global catastrophic risks as a unified class of problems, spanning exogenous risks (such as supervolcanoes, asteroid impacts and stellar phenomena) and endogenous risks (including nuclear war, pandemics, rapid and severe climate change and advanced artificial intelligence). Methods and Results It surveys the key ERS risk domains, highlighting their potential to generate extensive morbidity and mortality worldwide, their tendency to amplify existing social and economic inequalities, and their interactions and cascading effects within tightly coupled biophysical and socio-political systems. The article then argues that ERS and public health share core aims—protecting the health of populations and reducing health inequities—and that the current separation between them constitutes a missed opportunity. Conclusion It calls for closer collaboration between ERS and public health as a way to strengthen health system resilience and global preparedness while reinforcing the foundational mission of public health in an increasingly risky world.
- 8 June 2026
- Published by BMJ in Considerations in Medicine
- Vol. 4 (1) , e000060
Why public health needs to engage with existential risk studies: a call for collaboration
Background Existential and global catastrophic risks are low-probability, high-impact threats with profound implications for population health and health equity, yet they remain largely outside mainstream public health activities. This article introduces Existential Risk Studies (ERS) as an emerging interdisciplinary field that analyses existential and global catastrophic risks as a unified class of problems, spanning exogenous risks (such as supervolcanoes, asteroid impacts and stellar phenomena) and endogenous risks (including nuclear war, pandemics, rapid and severe climate change and advanced artificial intelligence). Methods and Results It surveys the key ERS risk domains, highlighting their potential to generate extensive morbidity and mortality worldwide, their tendency to amplify existing social and economic inequalities, and their interactions and cascading effects within tightly coupled biophysical and socio-political systems. The article then argues that ERS and public health share core aims—protecting the health of populations and reducing health inequities—and that the current separation between them constitutes a missed opportunity. Conclusion It calls for closer collaboration between ERS and public health as a way to strengthen health system resilience and global preparedness while reinforcing the foundational mission of public health in an increasingly risky world.
- 3 May 2026
- Published by Taylor & Francis in Infectious Diseases
- Vol. 58 (6) , 656-660
The AIxBio convergence: a call to action for infectious diseases clinicians
- 3 May 2026
- Published by Taylor & Francis in Infectious Diseases
- Vol. 58 (6) , 656-660
The AIxBio convergence: a call to action for infectious diseases clinicians